Status:
UNKNOWN
Clinical Phenotypes in Persons With Hip Osteoarthritis and Prognostic Factors for Outcome After Total Hip Arthroplasty
Lead Sponsor:
Hasselt University
Collaborating Sponsors:
Bijzonder onderzoeksfonds (BOF)
Ziekenhuis Oost-Limburg
Conditions:
Hip Osteoarthritis
Total Hip Arthroplasty
Eligibility:
All Genders
Brief Summary
This prospective longitudinal cohort study aims (1) to identify clinical phenotypes in persons with hip osteoarthritis and after total hip arthroplasty, and (2) to identify prognostic factors for outc...
Detailed Description
Osteoarthritis (OA) is one of the leading causes of pain and disability worldwide, with more than 300 million people currently affected by the disease. The hip joint is clinically one of the most affe...
Eligibility Criteria
Inclusion
- Persons with a confirmed clinical or radiographic primary diagnosis of hip osteoarthritis who will undergo total hip arthroplasty (THA)
Exclusion
- Rheumatoid arthritis or other rheumatic diseases
- Another pathological condition explaining the symptoms (e.g. avascular necrosis)
- Neurological condition (e.g. Parkinson's disease, stroke...) significantly influencing the symptoms of hip osteoarthritis.
- Revision THA
- History of pathological fractures (e.g. osteoporosis, tumor...)
- Contralateral THA during follow-up period
- Total knee arthroplasty (TKA) during follow-up period
- Another surgery planned during follow-up period
Key Trial Info
Start Date :
May 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05265858
Start Date
May 4 2021
End Date
February 1 2024
Last Update
March 4 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Heuppraktijk
Herselt, Antwerpen, Belgium, 2230
2
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium, 3600